The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer
$ 15.00 · 4.8 (98) · In stock
Rare molecular subtypes of lung cancer
2022肺癌靶标热点追击,ERRα/LTK/EMSY初露锋芒-源井生物- 知乎
PDF] Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer
Full article: The CLIP1–LTK fusion: anew oncogenic driver in non-small-cell lung cancer?
Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect
PDF] Identification of a RAS-activating TMEM87A–RASGRF1 Fusion in
Clinical and Translational Implications of RET Rearrangements in Non–Small Cell Lung Cancer - ScienceDirect
Empire Genomics Interviews With Today's Leading Researchers & Clinicians
LC-SCRUM-Asiaの遺伝子スクリーニングで肺がんの新しいドライバー遺伝子「CLIP1-LTK融合遺伝子」を世界で初めて発見
Comparison of ALK and LTK structure and sequence. (A) Schematic of